Australian device legislation
This article was originally published in The Gray Sheet
Executive Summary
Therapeutics Goods Administration is working with the Medical Industry Association of Australia to hold a series of workshops in late May and early June to educate industry on the new regulatory framework slated for implementation as early as the second half of 2002, according to a 1TGA release. The Therapeutic Goods Amendment (Medical Devices) Bill 2002 and the Therapeutic Goods (Charges) Amendment Bill were passed by the Australian Parliament March 21. The framework set out in the bills is based on Global Harmonization Task Force guidelines (2"The Gray Sheet" Nov. 26, 2001, p. 18)...
You may also be interested in...
Australia Drafting New In Vitro Diagnostic Legislation
An Australian expert panel on in vitro diagnostics is drafting a discussion paper addressing regulatory reform of IVDs. The document is expected to be available for comment in July
Proposed Australian Device Approval System Has Web-Based Application
Legislation that would authorize a new regulatory system for medical devices will be reintroduced into the Australian Parliament as early as March
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.